Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Byrd

Showing results (21-30 of 681) with videos related to

Pageof 69
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2020
Next-Generation Bruton Tyrosine Kinase InhibitorsDeborah M Stephens, John C Byrd
Seminars in Hematology|March 31, 2010
Rituximab in chronic lymphocytic leukemiaSamantha M Jaglowski, John C Byrd
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2012
Novel therapies and their integration into allogeneic stem cell transplant for chronic lymphocytic leukemiaSamantha M Jaglowski, John C Byrd
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
Comprehensive single nucleotide polymorphism study supports the role of MDM2 in p53-competent chronic lymphocytic leukemiaDavid M Lucas, John C Byrd
Cancer Cell|January 15, 2016
Venetoclax Adds a New Arrow Targeting Relapsed CLL to the QuiverKerry A Rogers, John C Byrd
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
CS1-directed monoclonal antibody therapy for multiple myelomaDon M Benson, John C Byrd
Blood|January 16, 2019
How I manage ibrutinib intolerance and complications in patients with chronic lymphocytic leukemiaDeborah M Stephens, John C Byrd
Nature Reviews. Clinical Oncology|December 7, 2011
Chemotherapy: New FluCam combination therapy has familiar limitationsJennifer A Woyach, John C Byrd
The New England Journal of Medicine|May 10, 2023
Time-Limited Initial Therapy for Young, Fit Patients with CLLJennifer A Woyach, John C Byrd
Blood|January 8, 2014
How will B-cell-receptor-targeted therapies change future CLL therapy?Jeffrey A Jones, John C Byrd
Pageof 69

Showing results (21-30 of 681) with videos related to

Sort By:
Pageof 69
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2020
Next-Generation Bruton Tyrosine Kinase InhibitorsDeborah M Stephens, John C Byrd
Seminars in Hematology|March 31, 2010
Rituximab in chronic lymphocytic leukemiaSamantha M Jaglowski, John C Byrd
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2012
Novel therapies and their integration into allogeneic stem cell transplant for chronic lymphocytic leukemiaSamantha M Jaglowski, John C Byrd
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
Comprehensive single nucleotide polymorphism study supports the role of MDM2 in p53-competent chronic lymphocytic leukemiaDavid M Lucas, John C Byrd
Cancer Cell|January 15, 2016
Venetoclax Adds a New Arrow Targeting Relapsed CLL to the QuiverKerry A Rogers, John C Byrd
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
CS1-directed monoclonal antibody therapy for multiple myelomaDon M Benson, John C Byrd
Blood|January 16, 2019
How I manage ibrutinib intolerance and complications in patients with chronic lymphocytic leukemiaDeborah M Stephens, John C Byrd
Nature Reviews. Clinical Oncology|December 7, 2011
Chemotherapy: New FluCam combination therapy has familiar limitationsJennifer A Woyach, John C Byrd
The New England Journal of Medicine|May 10, 2023
Time-Limited Initial Therapy for Young, Fit Patients with CLLJennifer A Woyach, John C Byrd
Blood|January 8, 2014
How will B-cell-receptor-targeted therapies change future CLL therapy?Jeffrey A Jones, John C Byrd
Pageof 69